TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26362692

Group type: EXPERIMENTAL
Intervention: AS cognitive concerns intervention
Number of subjects: 54

Group type: COMPARATOR
Intervention: Health information control intervention
Number of subjects: 54
Study: 23126316

Group type: EXPERIMENTAL
Intervention: Diode laser GaAlAs, energy density of 4 J/cm(2), power of 100 mW, wavelength in the infrared spectrum, for 10 seconds per point on 10 points, total dose of 40 J/cm(2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo group (simulated laser application for 60 seconds per point on 10 points)
Number of subjects: 60
Study: 21439849

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids plus α-tocopherol (920 mg EPA, 760 mg DHA, 8 mg α-tocopherol per day)
Number of subjects: 25

Group type: COMPARATOR
Intervention: α-tocopherol supplement (100 mg/week resulting in 14.2 mg/day)
Number of subjects: 25
Study: 18310524

Group type: EXPERIMENTAL
Intervention: Dexamethasone or tadalafil (prophylactic treatment)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 24
Study: 16503545

Group type: EXPERIMENTAL
Intervention: Selaginella (30 g) daily in 50 ml decoction during the entire course of radiotherapy
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Selaginella (30 g) daily in the late course of radiotherapy
Number of subjects: 180

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 180
Study: 12669010

Group type: EXPERIMENTAL
Intervention: High-monounsaturated-fat diet
Number of subjects: 26

Group type: COMPARATOR
Intervention: High-carbohydrate diet
Number of subjects: 26
Study: 10668767

Group type: EXPERIMENTAL
Intervention: Subjects with SCI who had a history of lower extremity pathologic fracture
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Subjects with SCI who had no fracture history
Number of subjects: 30

Group type: COMPARATOR
Intervention: Controls (men without known orthopedic or neurologic impairments)
Number of subjects: 30
Study: 9055782

Group type: EXPERIMENTAL
Intervention: Incision and drainage (I&D) of cutaneous abscesses
Number of subjects: 50
Study: 8345163

Group type: EXPERIMENTAL
Intervention: Fluoxetine hydrochloride 20 mg/day
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 3886298

Group type: EXPERIMENTAL
Intervention: 1600 mg ibuprofen 4-times daily
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 750 mg naproxen twice daily
Number of subjects: 75
Study: 29061311

Group type: EXPERIMENTAL
Intervention: Penicillin V 1.6 million units
Number of subjects: 43

Group type: COMPARATOR
Intervention: Amoxicillin 1000mg three times per day for 10 days
Number of subjects: 43
Study: 30248105

Group type: EXPERIMENTAL
Intervention: Nilvadipine (8 mg sustained-release, once daily after breakfast)
Number of subjects: 511

Group type: COMPARATOR
Intervention: Placebo (matched)
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Nilvadipine
Number of subjects: 511

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 511
Study: 26537907

Group type: EXPERIMENTAL
Intervention: Transanal TME (TaTME)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Laparoscopic TME
Number of subjects: 0
Study: 1316259

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (15,000 aXaU) administered 2 hours before surgery (Group A, 19 patients)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (15,000 aXaU) administered 2 hours after surgery (Group B, 21 patients)
Number of subjects: 40
Study: 22958237

Group type: EXPERIMENTAL
Intervention: Low vision rehabilitation (LVR) with 2 or 3 therapy sessions (1½ to 2½ hours) and homework to teach effective use of remaining vision and LV devices.
Number of subjects: 330

Group type: COMPARATOR
Intervention: Basic low vision (LV) with devices dispensed by the optometrist without LV therapy, contact time for dispensing is one hour or less.
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Low vision rehabilitation (LVR)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Basic low vision (LV)
Number of subjects: 330
Study: 20149619

Group type: EXPERIMENTAL
Intervention: LPro (0.50 g protein·kg body weight⁻¹·day⁻¹)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: MPro (0.75 g protein·kg body weight⁻¹·day⁻¹)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: HPro (1.00 g protein·kg body weight⁻¹·day⁻¹)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Diet-by-age interaction
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Diet alone
Number of subjects: 22
Study: 18686739

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg once daily
Number of subjects: 554

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 554
Study: 15917519

Group type: EXPERIMENTAL
Intervention: Linezolid (600 mg every 12 h, intravenously or orally)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Vancomycin (1 g every 12 h, intravenously)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 285

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Linezolid and Vancomycin
Number of subjects: 285
Study: 14733991

Group type: EXPERIMENTAL
Intervention: Supervisory safety‐oriented interaction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-intervention period
Number of subjects: 0
Study: 10327426

Group type: EXPERIMENTAL
Intervention: Psilocybin (PSI; 0.2 mg/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 3,4‐methylenedioxyethylamphetamine (MDE; 2 mg/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: d‐methamphetamine (METH; 0.2‐0.4 mg/kg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (word repetition task)
Number of subjects: 24
Study: 8619714

Group type: EXPERIMENTAL
Intervention: Autotransfusion (10 mL/kg of whole blood removed before cardiopulmonary bypass)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 100
Study: 1684515

Group type: EXPERIMENTAL
Intervention: Cetirizine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Terfenadine
Number of subjects: 6
Study: 6744776

Group type: EXPERIMENTAL
Intervention: Sotalol, 40 to 160 mg/day
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 30940171

Group type: EXPERIMENTAL
Intervention: Sacrospinous hysteropexy (SSH)
Number of subjects: 424

Group type: COMPARATOR
Intervention: Modified Manchester operation (MM)
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: SSH and MM
Number of subjects: 424
Study: 29480035

Group type: EXPERIMENTAL
Intervention: 100,000 IU vitamin D3/month for 12 months (200,000 IU at baseline)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 101
Study: 27245666

Group type: EXPERIMENTAL
Intervention: Peritoneal closure during LSH
Number of subjects: 104

Group type: COMPARATOR
Intervention: Non-closure during LSH
Number of subjects: 104
Study: 24716674

Group type: EXPERIMENTAL
Intervention: Video of an expert nurse role model
Number of subjects: 275

Group type: COMPARATOR
Intervention: No video (control group)
Number of subjects: 275
Study: 22080391

Group type: EXPERIMENTAL
Intervention: Nutridrink®
Number of subjects: 60

Group type: COMPARATOR
Intervention: Water (placebo)
Number of subjects: 60
Study: 20730429

Group type: EXPERIMENTAL
Intervention: Pectoral fascia preservation
Number of subjects: 247

Group type: COMPARATOR
Intervention: Pectoral fascia removal
Number of subjects: 247
Study: 17992396

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.2 mg/kg, three times at intervals of 36 hours)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 17377082

Group type: EXPERIMENTAL
Intervention: Propofol-remifentanil anesthesia
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sevoflurane anesthesia
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both groups (propofol-remifentanil and sevoflurane)
Number of subjects: 39
Study: 15010626

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 0
Study: 10865301

Group type: EXPERIMENTAL
Intervention: Intensive, standardized, 8‐week, in‐hospital cognitive rehabilitation program (n=67)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Limited home rehabilitation program with weekly telephone support from a psychiatric nurse (n=53)
Number of subjects: 120
Study: 9095441

Group type: EXPERIMENTAL
Intervention: Viewing videotapes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not viewing videotapes
Number of subjects: 0
Study: 8232944

Group type: EXPERIMENTAL
Intervention: 300 mg lamotrigine
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: 500 mg lamotrigine
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study: 3725655

Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 35

Group type: COMPARATOR
Intervention: Ticarcillin plus tobramycin
Number of subjects: 35
Study: 31750922

Group type: EXPERIMENTAL
Intervention: Structured preventive person-centred consultations with general practitioners (2 sessions)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Structured preventive consultations
Number of subjects: 209
Study: 30901345

Group type: EXPERIMENTAL
Intervention: Active repetitive transcranial magnetic stimulation (5Hz)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study: 28628601

Group type: EXPERIMENTAL
Intervention: Remote-telementored ultrasound (RTMUS)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Remote-mentored Resuscitative-surgery for torso hemorrhage-control
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Damage Control Surgery (DCS) in weightlessness (0g)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Remote-mentored ultrasound (RTMUS) by an ultrasound-naïve Firefighter
Number of subjects: 2

Group type: COMPARATOR
Intervention: Remote-mentoring for MedTechs conducting Resuscitative-surgery
Number of subjects: 2
Study: 26214076

Group type: EXPERIMENTAL
Intervention: 8-hr abstinence-only intervention
Number of subjects: 509

Group type: COMPARATOR
Intervention: 8-hr control intervention targeting physical activity and diet
Number of subjects: 509
Study: 24182630

Group type: EXPERIMENTAL
Intervention: Behavioral activation for depression followed by a lifestyle intervention
Number of subjects: 355

Group type: COMPARATOR
Intervention: Lifestyle intervention with attention control
Number of subjects: 355
Study: 21315441

Group type: EXPERIMENTAL
Intervention: Wireless implantable haemodynamic monitoring (W-IHM) system
Number of subjects: 550

Group type: COMPARATOR
Intervention: Standard of care alone (control group)
Number of subjects: 550
Study: 18982016

Group type: EXPERIMENTAL
Intervention: Genetic variation in the tenomodulin (TNMD) gene
Number of subjects: 5298

Group type: EXPERIMENTAL
Intervention: Men from the Finnish Diabetes Prevention Study (DPS)
Number of subjects: 5298

Group type: COMPARATOR
Intervention: Women
Number of subjects: 5298
Study: 16562686

Group type: EXPERIMENTAL
Intervention: Sevoflurane‐N2O inhalation anaesthesia with LMA
Number of subjects: 80

Group type: COMPARATOR
Intervention: Propofol‐ketamine total intravenous anaesthesia (TIVA)
Number of subjects: 80
Study: 12973819

Group type: EXPERIMENTAL
Intervention: 500-mg clarithromycin tablet
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reference formulation
Number of subjects: 24
Study: 11121914

Group type: COMPARATOR
Intervention: Ursodeoxycholic acid 500 mg/daily plus placebo (UDCA group, n=44)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid 500 mg/daily plus colchicine 1 mg/daily (UDCA/C group, n=46)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid 500 mg/daily plus colchicine 1 mg/daily (UDCA/C group)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ursodeoxycholic acid 500 mg/daily plus placebo (UDCA group)
Number of subjects: 90
Study: 8941105

Group type: EXPERIMENTAL
Intervention: Carvedilol (n = 232)
Number of subjects: 366

Group type: COMPARATOR
Intervention: Placebo (n = 134)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 366
Study: 1610160

Group type: EXPERIMENTAL
Intervention: Untasted salt tablets (120 mmol/day)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 2858466

Group type: EXPERIMENTAL
Intervention: Propranolol (160 mg/day)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg/day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 30768418

Group type: EXPERIMENTAL
Intervention: Attachment-Based Family Therapy (ABFT)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Family-Enhanced Nondirective Supportive Therapy (FE-NST)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Both ABFT and FE-NST
Number of subjects: 129
Study: 29636396

Group type: EXPERIMENTAL
Intervention: Electrical brain stimulation in the medial temporal lobe (MTL) during verbal memory tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electrical brain stimulation in the medial temporal lobe (MTL) during spatial tasks
Number of subjects: 0
Study: 27008286

Group type: EXPERIMENTAL
Intervention: Epidrum guidance (group E)
Number of subjects: 150

Group type: COMPARATOR
Intervention: LOR technique with a syringe (group C)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Overall (both groups)
Number of subjects: 150
Study: 24584633

Group type: COMPARATOR
Intervention: Contact heat-evoked potentials (CHEPs) applied to the skin of the leg above the internal malleolus (AIM) with a peak thermal stimulus of 47 °C.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Contact heat-evoked potentials (CHEPs) applied to the skin of the waist at the anterior superior iliac spine (ASIS) level.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Contact heat-evoked potentials (CHEPs) applied to the skin of the leg above the internal malleolus (AIM).
Number of subjects: 60
Study: 23016888

Group type: EXPERIMENTAL
Intervention: Monoblock appliance
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: SILENT NITE (two-piece appliance)
Number of subjects: 16
Study: 20124795

Group type: COMPARATOR
Intervention: WT (Progressive Resistance Training)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: WT + ST (Progressive Resistance Training + Static Stretching)
Number of subjects: 32
Study: 17402962

Group type: EXPERIMENTAL
Intervention: Standard care with supplemental acupressure for eight weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Standard care with supplemental sham acupressure for eight weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 35
Study: 15321808

Group type: COMPARATOR
Intervention: Met (30 mg methionine/kg body wt)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: MetSer (30 mg methionine + 60.6 mg serine/kg body wt)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: MetCys (30 mg methionine + 12.3 mg cystine/kg body wt)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Protein (30 mg methionine + 60.6 mg serine + 12.3 mg cystine/kg body wt)
Number of subjects: 24
Study: 11958386

Group type: EXPERIMENTAL
Intervention: New progressive treadmill protocol (1.0 mile/h or 1.6 km/h)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Established protocol (2.0 miles/h or 3.2 km/h)
Number of subjects: 11
Study: 9622220

Group type: EXPERIMENTAL
Intervention: 4G/5G genotype in myocardial infarction patients
Number of subjects: 128

Group type: COMPARATOR
Intervention: 4G/5G genotype in control patients
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Total frequencies of 4G and 5G alleles
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: PAI‐1 promoter genotype
Number of subjects: 128
Study: 7709864

Group type: EXPERIMENTAL
Intervention: Change in health education message during antenatal sessions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Distribution of sugar-coated chloroquine tablet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined intervention of health education message change and product change
Number of subjects: 0
Study: 3315176

Group type: EXPERIMENTAL
Intervention: Lorazepam (1.5 mg/m2)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Diphenhydramine (50 mg)
Number of subjects: 120
Study: 31451082

Group type: EXPERIMENTAL
Intervention: Food Store Environment Examination (FoodSee) using wearable cameras for 4 days recording images every 7 seconds.
Number of subjects: 168
Study: 30110194

Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Nivolumab 1 mg/kg plus ipilimumab 3 mg/kg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg plus ipilimumab 1 mg/kg
Number of subjects: 160
Study: 26641212

Group type: EXPERIMENTAL
Intervention: Total testosterone concentrations
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Bioavailable testosterone
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Sex hormone binding globulin (SHBG)
Number of subjects: 508
Study: 25087939

Group type: EXPERIMENTAL
Intervention: Mesh group (polypropylene mesh)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonmesh group (standard abdominal wall closure)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mesh group
Number of subjects: 0
Study: 22170363

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D fortified orange juice (350 mg Ca and 100 IU vitamin D per 240 mL serving)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control group (unfortified regular or lite orange juice)
Number of subjects: 171
Study: 20167141

Group type: EXPERIMENTAL
Intervention: Mometasone furoate dry-powder inhaler (MF-DPI), 100 micrograms b.i.d.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Mometasone furoate dry-powder inhaler (MF-DPI), 200 micrograms b.i.d.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Mometasone furoate dry-powder inhaler (MF-DPI), 400 micrograms b.i.d.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 17345064

Group type: EXPERIMENTAL
Intervention: Topiramate (75 mg/day for 9 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 15711861

Group type: EXPERIMENTAL
Intervention: Lateral internal sphincterotomy up to the dentate line
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lateral internal sphincterotomy up to the fissure apex
Number of subjects: 0
Study: 12163878

Group type: EXPERIMENTAL
Intervention: School-based health education
Number of subjects: 793

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 793
Study: 10319784

Group type: EXPERIMENTAL
Intervention: Epidural clonidine (10 micrograms/kg in 7 ml saline followed by 6 micrograms/kg/h for 12 hours)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bupivacaine (0.5% 7 ml followed by 0.25% 7 ml/h for 12 hours)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bupivacaine (0.25% 7 ml followed by 0.125% 7 ml/h for 12 hours)
Number of subjects: 60
Study: 8916485

Group type: EXPERIMENTAL
Intervention: Directional coronary atherectomy
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Percutaneous transluminal coronary angioplasty
Number of subjects: 1012
Study: 1841829

Group type: EXPERIMENTAL
Intervention: Oral immunoglobulin preparation (monomeric IgG, 90% concentration), 500 mg per day, subdivided into 5 doses for 65 neonates
Number of subjects: 132

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 132
Study: 6138932

Group type: EXPERIMENTAL
Intervention: Beta-adrenergic stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alpha-adrenergic stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Beta-adrenergic blockade
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concomitant alpha-blockade
Number of subjects: 0
Study: 31276501

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise training program (2 sessions/day for 5-7 consecutive days)
Number of subjects: 370
Study: 28210859

Group type: EXPERIMENTAL
Intervention: Peloid therapy + splint treatment (every night for 6 weeks + five consecutive days a week for 2 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (splint treatment alone, every night for 6 weeks)
Number of subjects: 70
Study: 27697671

Group type: EXPERIMENTAL
Intervention: 30-min computer-guided mindset intervention
Number of subjects: 96

Group type: COMPARATOR
Intervention: Supportive-therapy control
Number of subjects: 96
Study: 24592984

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC) plus Cimicifugae racemosae (CR)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Clomiphene citrate (CC)
Number of subjects: 194
Study: 21943634

Group type: EXPERIMENTAL
Intervention: Fixed 'nondeformable' fundoplication
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Nissen fundoplication
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Partial fundoplication
Number of subjects: 512

Group type: COMPARATOR
Intervention: Medical treatment (MT)
Number of subjects: 512
Study: 19124693

Group type: EXPERIMENTAL
Intervention: Delta9-Tetrahydrocannabinol (10 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cannabidiol (600 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 17300297

Group type: EXPERIMENTAL
Intervention: Oral intubation
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Nasal intubation
Number of subjects: 62
Study: 15142103

Group type: EXPERIMENTAL
Intervention: Optocal Plus (small portion size)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Optocal Plus (medium portion size)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Optocal Plus (large portion size)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Mandibular implant‐retained overdentures
Number of subjects: 67

Group type: COMPARATOR
Intervention: Conventional complete dentures
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 67
Study: 11104841

Group type: EXPERIMENTAL
Intervention: zolpidem (10 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: triazolam (0.25 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: temazepam (30 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study: 9100427

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) at doses of 5 mg, 10 mg, 15 mg, and 20 mg
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 76